Шрифт:
53. Barrett, A. and others, 2006. How much will herceptin really cost? BMJ, 333, 1118–1120.
54. Daily Mail, Monday, 9 October, 2006.
55. www.ahrq.gOv/news/press/pr2002/brchempr.htm
56.16.htm
56.7_16. htm
57. Gottlieb, Scott, 2002. Tamoxifen may increase risk of uterine sarcoma, BMJ, 325, 7.
58.htm
59. Mayor, Susan, 2002. Anastrozole shows promise for early breast cancer. BMJ, 324, 1539
60. www.gene.com/gene/products/information/oncology/hercep-tin;
www.herceptin.com/herceptin/physician/pi.htm
61.htm
62. www.ahrq.gov/news/press/pr2002/brchempr.htm
63. New Scientist, 20 January, 2007.
64. Editorial, New Scientist, 31 March, 2007.
65. Josefson, Deborah, 2002. Doctors warned to be wary of new drugs. BMJ, 324, 1113.
66. Garattini, Silvio and Bertele, Vittorio, 2002. Efficacy, safety, and cost of new anticancer drugs. BMJ, 325, 269–271.
67. www.cancer.gov
68. Modified after: Chemotherapy and You: A Guide to Self-Help During Cancer Treatment. Information about what to expect during chemotherapy and what patients can do to take care of themselves during and after treatment NIH Publication #99-1136: www.cancer.gov/cancerinfo/chemorherapy-and-you
69. Smith, I. and Chue, S., 2006. Medical treatment of early breast cancer. BMJ, 332, 162–181.
70. Allison, R. and others, 2006.Photodiagnosis and photodynamic therapy, 3, 139–146.
71. Fritsch, С. and Ruzika, Т., 2003. Fluorescence diagnosis and photodynamic therapy of skin diseases atlas and handbook. Vien: Springer-Verlag.
72. Coulter; Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.
73. Coulter, Angela, 2003. Killing the goose that laid the golden egg. BMJ, 326, 1280.
74. Ernst, E., 2003. Herbal medicines put into context. BMJ, 327, 881–882.
75. Waxman, Jonathan, 2001. The Prostate Cancer Book. London: Vermillion.
76. Dyer, Owen, 2003. Aspirin could be used to prevent cancer. BMJ, 326, 565.
77. Flower, Rod, 2003. What are all the things that aspirin does? BMJ, 327, 572–573.
78. UK limits use of aspirin by under 16s. BMJ, 2002, 324, 1294.
79. Astralagus. ICON, 2002, 1 (3), 23.
80. Bartram, Т., 1998. Bartram’s encyclopedia of herbal medicine. Robinson publishing.
81. Campbell, T.C. and Campbell, T.M., 2006. The China Study. Benbella Books.
82. Greenwald, Peter, 2002. Cancer chemoprevention. BMJ, 324, 714–718.
Дополнение к главе 2
1. Clarke, M.F. and Becker, M.W, 2006. Stem cells: the real culprits in cancer? Scientific American, July 2006, 53–59.
2. Study reveals how growth factors affect human stem cells. www.hhmi.org/news/melton.hmtl
3. Murray, R.K., Granner, D.K., Mayes, P.A. and Rodwell, VW, 1990. Harper's Biochemistry. Appleton and Lange Norwalk, CT, p. 653.
4. Woolf, Neville, 1998. Pathology, Basic and Systemic. WB. Saunders Publishing Co., Chapter 28, p. 274, Figure 28.
5. www.intouchlive.com/cancergenetics/onco.htm
6. Ludwig, Т., Fisher, P., Ganesan, S. and Efstratiadis, 2001. Tum-origenesis in mice carrying a truncating BRCA1 mutation. Genes and Development, Vol. 15 (10), 1188–1193.
7. Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, Т., Hennighausen, L., Wynshaw-Boris, A. and Deng, C.X. 1999. Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genetics, Vol. 22 (1), 37–43.
8. Pauli, T.T, Cortez, D., Bowers, B., Elledge, S.J. and Geliert, M., 2001. Direct DNA binding by BRCA1. Proceedings of the National Academy of Sciences of the USA, Vol. 98 (11), 6086–6091.
9. Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, В., Tronick, S., King, M.C., Page, D.L. and Holt, J.T., 1996. BRCA1 is secreted and exhibits properties of a granin. Nature Genetics, 12, 303–308; www.mc.vander-bilt.edu/cancer/research/ roster/jensen.html